-
The "traditional" model of a rapid response team (RRT), as outlined by the Boston-based Institute for Healthcare Improvement (IHI) and employed by a large number of hospitals, is often driven by (and mainly staffed by) the ICU or other staff with critical care experience, such as critical care nurses.
-
While The Joint Commission and other organizations are paying a great deal of attention to safety in drug administration, a new report from the Agency for Healthcare Research and Quality (AHRQ) indicates we may be doing a better job than many have thought.
-
According to the American Hospital Association's (AHA) second annual survey of hospital health IT use, hospitals continue to accelerate their use of health information technology, with 68% reporting that electronic health records had been fully or partially implemented as of fall 2006.
-
-
Has your treatment of menopausal women changed since the initial findings released from the Women's Health Initiative (WHI) randomized, controlled trials of hormone therapy (HT)? Findings from a just-published secondary analysis of data from the WHI indicate that women who initiated HT closer to menopause tended to have reduced risk of coronary heart disease (CHD), while women further from menopause tended to have a slightly higher risk for the disease.
-
Global policies are being updated with the recent issuance of recommendations from an expert consultation on male circumcision for HIV prevention.1 But what impact do the recommendations have on your practice?
-
In 1992, reproductive health advocates estimated that emergency contraceptive pills (ECPs) could prevent half of all unintended pregnancies and abortions in the United States each year.
-
Consider the following patients: a 15-year-old young mother, a 30-year-old married woman with no previous pregnancies, a 30-year-old single woman with no children, and a 30-year-old HIV-positive woman with three children. When discussing contraceptive options, do you include intrauterine contraception in talking with these women?
-
-
Update your practice when it comes to treatment of gonorrhea: The Centers for Disease Control and Prevention (CDC) no longer recommends the fluoroquinolone antibiotics ciprofloxacin, ofloxacin, and levofloxacin as a treatment for gonorrhea in the United States.
